2024–2025
- Suzhou Fuent Pharmaceutical Co., Ltd. conducted its Phase I clinical trial in China at Zhongshan Hospital of Fudan University, Peking University Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, Jiangsu Provincial People’s Hospital, and Zhejiang Cancer Hospital.